Table 1.
Demographics and Clinical Characteristics of the Migraine Population.
| Optum CDM N = 56 662 | MarketScan N = 176,724 | |
|---|---|---|
| Age group, years | ||
| 18–24 | 4843 (8.5) | 16 806 (9.5) |
| 25–34 | 10 004 (17.7) | 28 474 (16.1) |
| 35–44 | 15 500 (27.4) | 46 320 (26.2) |
| 45–64 | 26 315 (46.4) | 85 124 (48.2) |
| Sex | ||
| Female | 47 731 (84.2) | 150 256 (85.0) |
| Male | 8927 (15.8) | 26 468 (15.0) |
| Insurance plan type | ||
| Preferred provider organization | 722 (1.3) | 97 435 (55.1) |
| Point of service | 42 845 (75.6) | 14 287 (8.1) |
| Exclusive provider organization | 6445 (11.4) | 34 886 (19.7) |
| Health maintenance organization | 6334 (11.2) | 18 710 (10.6) |
| Other or unknown | 316 (0.6) | 11 406 (6.5) |
| Presence of chronic migraine diagnosis | 14 203 (25.1) | 47 669 (27.0) |
| Elixhauser comorbidity count | ||
| 0 | 12 974 (22.9) | 43 100 (24.4) |
| 1 | 14,359 (25.3) | 47 288 (26.8) |
| 2–3 | 17 968 (31.7) | 57 004 (32.3) |
| 4–5 | 7273 (12.8) | 20 328 (11.5) |
| ≥6 | 4088 (7.2) | 9004 (5.1) |
| Migraine-related comorbidities | ||
| Mood disorder | 16 974 (30.0) | 46 609 (26.4) |
| Sleep disturbances | 13 838 (24.4) | 39 163 (22.2) |
| Rhinitis | 10 744 (19.0) | 31 614 (17.9) |
| Pain | 6640 (11.7) | 17 173 (9.7) |
| Inflammatory bowel syndrome | 3443 (6.1) | 8853 (5.0) |
| Epilepsy | 2135 (3.8) | 6267 (3.5) |
Abbreviations: CDM, Clinformatics Data Mart; CV, cardiovascular.
All data are n (%).